Britain will start to roll out Merck's molnupiravir Covid-19 antiviral pill through a drug trial later this month, Reuters quotes Susan Hopkins, Chief Medical Adviser at the UK Health Security Agency as saying.
Last week Britain became the first country in the world to approve the potentially game-changing Covid-19 antiviral pill, jointly developed by US-based Merck & Co Inc and Ridgeback Biotherapeutics.
Asked about the molnupiravir approval, Hopkins told BBC television: “That is great news and it will start to be rolled out through a drug trial in the end of this month/the beginning of December.”
